Publications by authors named "Guiovana-Fernanda Osorio-Gomez"
Article Synopsis
- - Biological therapy, specifically brodalumab, shows promise in treating hidradenitis suppurativa (HS) by targeting the IL-17 receptor, which may play a role in the disorder's immune dysregulation.
- - A study involving 16 adults with moderate to severe HS found that 50% achieved an improvement in symptoms and experienced a significant decrease in disease severity after 16 weeks of brodalumab treatment.
- - The treatment was generally safe, with some patients experiencing mild adverse effects, suggesting that brodalumab is a viable option for those who did not respond to previous biologics like adalimumab.
Down syndrome (DS) has been related to a higher risk of hidradenitis suppurativa (HS). This cross-sectional study assessed DS patients with HS in a Spanish single-centre sample. DS participants presented a lower age of onset, age at diagnosis and time to diagnosis.
View Article and Find Full Text PDFObjectives: to evaluate the efficacy of glutamine in the prevention of the incidence of oral mucositis secondary to cancer therapies in patients with head and neck cancer (HNC). Secondary objectives were to know the incidence of odynophagia, interruptions of treatment and the requirements of analgesia and nasogastric tube.
Material And Methods: prospective cohort study of patients with squamous cell carcinoma of HNC treated with radiotherapy ± concomitant chemotherapy.